• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FIGS Releases Fourth Quarter and Full Year 2025 Financial Results

    2/26/26 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary
    Get the next $FIGS alert in real time by email

    Exceeded Top and Bottom Line Expectations

    Grew Q4 2025 Net Revenues 33.0% to a Record $201.9 Million

    Achieved Q4 2025 Net Income Margin of 9.2% and Adjusted EBITDA Margin of 13.2%

    Plans Low Double-Digit Net Revenues Growth and Margin Expansion in FY 2026

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/.

    Fourth Quarter 2025 Financial Highlights

    • Net revenues were $201.9 million, an increase of 33.0% year over year, primarily due to an increase in orders from new and existing customers and higher average order value ("AOV").(1)
      • Scrubwear net revenues were $154.9 million, an increase of 35.1% year over year.
      • Non-scrubwear net revenues were $47.0 million, an increase of 26.4% year over year.
      • U.S. net revenues were $164.2 million, an increase of 28.7% year over year.
      • International net revenues were $37.7 million, an increase of 55.1% year over year.
    • Gross margin was 62.9%, a decrease of 440 basis points year over year, reflecting higher tariffs and lapping the benefit from duty drawback claims in the same period last year. Additionally, results reflect a $5.6 million inventory write-off recorded during the period. These headwinds were partially offset by a lower discount rate in the period, as well as favorable freight rates.
    • Operating expenses were $108.3 million, an increase of 16.0% year over year. As a percentage of net revenues, operating expenses decreased to 53.6% from 61.4% in the same period last year, primarily due to lower stock-based compensation expense, lower fulfillment and shipping expenses, and fixed cost leverage.
    • Net income was $18.5 million, or $0.10 in diluted earnings per share, compared to net income of $1.9 million, or $0.01 in diluted earnings per share, in the same period last year.
    • Net income margin(2) was 9.2%, as compared to 1.2% in the same period last year.
    • Adjusted EBITDA(3) was $26.7 million, an increase of $5.7 million year over year.
    • Adjusted EBITDA margin(2)(3) was 13.2%, as compared to 13.9% in the same period last year.

    "FIGS' fourth quarter performance capped off a remarkable 2025, driven by execution that gained steady momentum throughout the year," said Trina Spear, Chief Executive Officer and Co-Founder. "Our 33% surge in Q4 net revenues was driven by successes across virtually every part of the business, while also lowering our discount rate for the period. With the COVID overhang past us and the structural advantages of this industry as tailwinds, we're excited to see our sustained success over the past few quarters continue into 2026. The opportunity to serve healthcare professionals globally is massive, and no one is better positioned than FIGS to capitalize on it."

    Full Year 2025 Financial Highlights

    • Net revenues were $631.1 million, an increase of 13.6% year over year, primarily driven by an increase in orders from new and existing customers and higher AOV.(3)
      • Scrubwear net revenues were $508.9 million, an increase of 14.3% year over year.
      • Non-scrubwear net revenues were $122.2 million, an increase of 10.6% year over year.
      • U.S. net revenues were $527.5 million, an increase of 11.2% year over year.
      • International net revenues were $103.6 million, an increase of 27.5% year over year.
    • Gross margin was 66.5%, a decrease of 110 basis points year over year, primarily due to higher tariffs and the inventory write-off recorded in Q4 2025, partially offset by a lower discount rate.
    • Operating expenses were $381.7 million, an increase of 2.2% year over year. As a percentage of net revenues, operating expenses decreased to 60.5% from 67.2% in the same period last year, primarily due to lower stock-based compensation expense, lower fulfillment expenses and higher brand marketing expenses in the prior year related to our 2024 Olympics campaign.
    • Net income was $34.3 million, or $0.19 in diluted earnings per share, compared to net income of $2.7 million, or $0.02 in diluted earnings per share, in the same period last year.
    • Net income margin(2) was 5.4%, as compared to 0.5% in the same period last year.
    • Adjusted EBITDA(3) was $74.5 million, an increase of $22.7 million year over year.
    • Adjusted EBITDA margin(2)(3) was 11.8%, as compared to 9.3% in the same period last year.
    • Free Cash Flow(3) was $53.0 million.

    Full Year 2025 Key Operating Metrics

    • Active customers(1) as of December 31, 2025 increased 9.4% year over year to 2.9 million.
    • Net revenues per active customer(1) was $216, an increase of 3.8% year over year.
    • AOV(1) was $120, an increase of 6.2% year over year, primarily driven by higher average unit retail due to product mix, higher units per transaction, and favorable discount and return rates.

    Full Year 2026 Financial Outlook

    Net Revenues growth vs. 2025

    up 10% to 12%

     

     

    Adjusted EBITDA Margin(2)(4)

    12.7% to 12.9%

    Sarah Oughtred, Chief Financial Officer, commented, "We exited 2025 with tremendous demand momentum, improving profitability and record cash on the balance sheet—each measure well ahead of expectations and a testament to the strength of our strategy and execution of our team. Our success positions us for a great 2026 with continuing growth from the core foundational elements of our business as well as from International, TEAMS and Community Hubs. Given our momentum and while still adopting a prudent mindset, we expect top line growth in 2026 of 10-12%, including growth in the low-20% range for Q1. At the same time, we expect increased profitability, even with the latest announcement calling for 15% global tariffs. Finally, our balance sheet remains a source of strength and financial flexibility, and we expect that to improve even further with strong cash flow driving expanded shareholder value."

    (1) "Active customers," "net revenues per active customer" and "average order value" are key operational and business metrics that are important to understanding the Company's performance. Please see the sections titled "Non-GAAP Financial Measures and Key Operating Metrics" and "Key Operating Metrics" below for information regarding how the Company calculates its key operational and business metrics and for comparisons of active customers, net revenues per active customer and average order value to the prior year period.

    (2) "Net income margin" and "adjusted EBITDA margin" are calculated by dividing net income and adjusted EBITDA by net revenues, respectively.

    (3) "Adjusted EBITDA," "adjusted EBITDA margin" and "free cash flow" are non-GAAP financial measures. Please see the sections titled "Non-GAAP Financial Measures and Key Operating Metrics" and "Reconciliations of GAAP to Non-GAAP Measures" below for more information regarding the Company's use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures.

    (4) The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income outlook because it is unable, without making unreasonable efforts, to project certain reconciling items. These items include, but are not limited to, future stock-based compensation expense, income taxes, expenses related to non-ordinary course disputes, and transaction costs. These items are inherently variable and uncertain and depend on various factors, some of which are outside of the Company's control or ability to predict. For more information regarding the Company's use of non-GAAP financial measures, please see the section titled "Non-GAAP Financial Measures and Key Operating Metrics."

    Conference Call Details

    FIGS management will host a conference call and webcast today at 2:00 p.m. PT / 5:00 p.m. ET to discuss the Company's financial and business results and outlook. To participate, please dial 1-646-844-6383 (US) or 1-833-470-1428 (International) and the conference ID 223631. The call is also accessible via webcast at ir.wearfigs.com. A recording will be available shortly after the conclusion of the call until 11:59 p.m. ET on March 5, 2026. To access the replay, please dial 1-929-458-6194 (US) or 1-866-813-9403 (International) and the conference ID 957212. An archive of the webcast will be available on FIGS' investor relations website at ir.wearfigs.com.

    Non-GAAP Financial Measures and Key Operating Metrics

    In addition to the GAAP financial measures set forth in this press release, the Company has included non-GAAP financial measures within the meaning of Regulation G and Item 10(e) of Regulation S-K. The Company uses "adjusted EBITDA" and "adjusted EBITDA margin" to provide useful supplemental measures that assist in evaluating its ability to generate earnings, provide consistency and comparability with its past financial performance and facilitate period-to-period comparisons of its core operating results as well as the results of its peer companies. The Company uses "free cash flow" as a useful supplemental measure of liquidity and as an additional basis for assessing its ability to generate cash. The Company calculates "adjusted EBITDA" as net income adjusted to exclude: other income (loss), net; gain/loss on disposal of assets; provision for income taxes; depreciation and amortization expense; stock-based compensation and related expense; transaction costs; and expenses related to non-ordinary course disputes. The Company calculates "adjusted EBITDA margin" by dividing adjusted EBITDA by net revenues. The Company calculates "free cash flow" as net cash (used in) provided by operating activities reduced by capital expenditures, including purchases of property and equipment and capitalized software development costs.

    Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included below under the heading "Reconciliations of GAAP to Non-GAAP Measures."

    The Company has also included herein "active customers," "net revenues per active customer" and "average order value," which are key operational and business metrics that are important to understanding Company performance. The Company believes the number of active customers is an important indicator of growth as it reflects the reach of the Company's digital platform, brand awareness and overall value proposition. The Company defines an active customer as a unique customer account that has made at least one purchase in the preceding 12-month period. In any particular period, the Company determines the number of active customers by counting the total number of customers who have made at least one purchase in the preceding 12-month period, measured from the last date of such period. The Company believes measuring net revenues per active customer is important to understanding engagement and retention of customers, and as such, the value proposition for its customer base. The Company defines net revenues per active customer as the sum of total net revenues in the preceding 12-month period divided by the current period active customers. The Company defines average order value as the sum of the total net revenues in a given period divided by the total orders placed in that period. Total orders are the summation of all completed individual purchase transactions in a given period. The Company believes its relatively high average order value demonstrates the premium nature of its products. As the Company expands into and increases its presence in additional product categories, price points and international markets, average order value may fluctuate.

    Active customers as of December 31, 2025 and 2024, respectively, net revenues per active customer as of December 31, 2025 and 2024, respectively, and average order value for the years ended December 31, 2025 and 2024, respectively, are presented below under the heading "Key Operating Metrics."

    About FIGS

    FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower, and serve current and future generations of healthcare professionals. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function, and style. We share stories about healthcare professionals' experiences in ways that inspire them. We build meaningful connections within the healthcare community that we created. Above all, we seek to make an impact for our community, including by advocating for them and always having their backs.

    We serve healthcare professionals both in the U.S. and internationally. We also serve healthcare institutions through our TEAMS platform.

    Forward Looking Statements

    This press release contains various forward-looking statements about the Company within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that are based on current management expectations, and which involve substantial risks and uncertainties that could cause actual results to differ materially from the results expressed in, or implied by, such forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking. These forward-looking statements generally are identified by the words "anticipate", "believe", "contemplate", "continue", "could", "estimate", "expect", "forecast", "future", "intend", "may", "might", "opportunity", "outlook", "plan", "possible", "potential", "predict", "project," "should", "strategy", "strive", "target", "will" or "would", the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including the Company's tailwinds, the Company's opportunity and positioning to serve healthcare professionals globally; the Company's expectations for 2026 with continuing growth from the core foundational elements of its business and from International, TEAMS and Community Hubs; the Company's expectation of topline growth in 2026 of 10-12%, including its growth expectations in the low-20% range for Q1; the Company's expectation of increased profitability; the Company's tariff expectations; the Company's expectations regarding its balance sheet; the Company's expectation that strong cash flow will drive expanded shareholder value; and the information under the section titled "Full Year 2026 Financial Outlook," such as the Company's outlook as to net revenues growth and adjusted EBITDA margin for the full year ending December 31, 2026; all of which reflect the Company's expectations based upon currently available information and data. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, the Company's actual results, performance or achievements may differ materially from those expressed or implied by the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements. The following important factors and uncertainties, among others, could cause actual results, performance or achievements to differ materially from those described in these forward-looking statements: the Company's ability to maintain its historical growth; the Company's ability to maintain profitability; the Company's ability to maintain the value and reputation of its brand; the Company's ability to attract new customers, retain existing customers, and to maintain or increase sales to those customers; the success of the Company's marketing efforts; the Company's ability to maintain a strong community of engaged customers and Ambassadors; negative publicity related to the Company's marketing efforts or use of social media; the Company's ability to successfully develop and introduce new, innovative and updated products; the competitiveness of the market for healthcare apparel; the Company's ability to maintain its key employees; the Company's ability to attract and retain highly skilled team members; risks associated with expansion into, and conducting business in, international markets; changes in, or disruptions to, the Company's shipping arrangements; the successful operation of the Company's fulfillment operations; the Company's ability to accurately forecast customer demand, manage its inventory, and plan for future expenses; the impact of changes in consumer confidence, shopping behavior and consumer spending on demand for the Company's products; the impact of macroeconomic trends on the Company's operations; the Company's reliance on a limited number of third-party suppliers; the impact of global trade policy on the Company's ability to source and distribute its products; the fluctuating costs of raw materials; the Company's ability to executed on its B2B growth strategy; the Company's ability to execute on its retail growth strategy; the Company's failure to protect proprietary, confidential or sensitive information or personal customer data or risks of cyberattacks; the Company's failure to protect its intellectual property rights; the fact that the operations of many of the Company's suppliers and vendors are subject to additional risks that are beyond its control; and other risks, uncertainties and factors discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2025 to be filed with the Securities and Exchange Commission ("SEC"), and the Company's other periodic filings with the SEC. The forward-looking statements in this press release speak only as of the time made and the Company does not undertake to update or revise them to reflect future events or circumstances.

    FIGS, INC.

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

     

     

    As of

     

    December 31,

    2025

     

    December 31,

    2024

    Assets

     

     

     

    Current assets

     

     

     

    Cash and cash equivalents

    $

    81,985

     

    $

    85,645

    Short-term investments

     

    218,863

     

     

    159,469

    Accounts receivable

     

    6,271

     

     

    8,625

    Inventory, net

     

    127,966

     

     

    115,759

    Prepaid expenses and other current assets

     

    12,200

     

     

    13,268

    Total current assets

     

    447,285

     

     

    382,766

    Non-current assets

     

     

     

    Property and equipment, net

     

    33,938

     

     

    35,274

    Operating lease right-of-use assets

     

    57,134

     

     

    50,497

    Deferred tax assets

     

    12,187

     

     

    11,643

    Investment in equity securities

     

    27,735

     

     

    27,534

    Other assets

     

    1,717

     

     

    2,073

    Total non-current assets

     

    132,711

     

     

    127,021

    Total assets

    $

    579,996

     

    $

    509,787

    Liabilities and stockholders' equity

     

     

     

    Current liabilities

     

     

     

    Accounts payable

    $

    18,187

     

    $

    9,401

    Operating lease liabilities

     

    8,175

     

     

    10,596

    Accrued expenses

     

    20,529

     

     

    42,316

    Accrued compensation and benefits

     

    17,194

     

     

    5,689

    Sales tax payable

     

    4,266

     

     

    3,705

    Gift card liability

     

    12,117

     

     

    9,604

    Deferred revenue

     

    3,990

     

     

    4,612

    Returns reserve

     

    4,171

     

     

    3,873

    Income tax payable

     

    1,894

     

     

    346

    Total current liabilities

     

    90,523

     

     

    90,142

    Non-current liabilities

     

     

     

    Operating lease liabilities, non-current

     

    51,829

     

     

    42,430

    Other non-current liabilities

     

    182

     

     

    83

    Total liabilities

     

    142,534

     

     

    132,655

    Commitments and contingencies

     

     

     

    Stockholders' equity

     

     

     

    Class A common stock — par value $0.0001 per share, 1,000,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 157,559,556 and 154,003,352 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively

     

    16

     

     

    15

    Class B common stock — par value $0.0001 per share, 150,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 8,283,641 shares issued and outstanding as of December 31, 2025 and December 31, 2024

     

    —

     

     

    —

    Preferred stock — par value $0.0001 per share, 100,000,000 shares authorized as of December 31, 2025 and December 31, 2024; zero shares issued and outstanding as of December 31, 2025 and December 31, 2024

     

    —

     

     

    —

    Additional paid-in capital

     

    338,526

     

     

    312,622

    Accumulated other comprehensive income

     

    196

     

     

    21

    Retained earnings

     

    98,724

     

     

    64,474

    Total stockholders' equity

     

    437,462

     

     

    377,132

    Total liabilities and stockholders' equity

    $

    579,996

     

    $

    509,787

    FIGS, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except share and per share data)

     

     

    Three months ended December 31,

     

    Year ended December 31,

     

     

    2025

     

     

    2024

     

     

    2025

     

     

    2024

     

    (unaudited)

     

     

     

     

    Net revenues

    $

    201,896

     

    $

    151,832

     

    $

    631,098

     

    $

    555,558

    Cost of goods sold

     

    74,830

     

     

    49,636

     

     

    211,259

     

     

    179,935

    Gross profit

     

    127,066

     

     

    102,196

     

     

    419,839

     

     

    375,623

    Operating expenses

     

     

     

     

     

     

     

    Selling

     

    42,899

     

     

    37,917

     

     

    145,851

     

     

    141,909

    Marketing

     

    28,326

     

     

    19,788

     

     

    93,105

     

     

    88,566

    General and administrative

     

    37,033

     

     

    35,591

     

     

    142,736

     

     

    142,883

    Total operating expenses

     

    108,258

     

     

    93,296

     

     

    381,692

     

     

    373,358

    Net income from operations

     

    18,808

     

     

    8,900

     

     

    38,147

     

     

    2,265

    Other income, net

     

     

     

     

     

     

     

    Interest income

     

    2,238

     

     

    2,639

     

     

    8,748

     

     

    11,242

    Other income

     

    307

     

     

    841

     

     

    312

     

     

    833

    Total other income, net

     

    2,545

     

     

    3,480

     

     

    9,060

     

     

    12,075

    Net income before provision for income taxes

     

    21,353

     

     

    12,380

     

     

    47,207

     

     

    14,340

    Provision for income taxes

     

    2,846

     

     

    10,495

     

     

    12,957

     

     

    11,620

    Net income

    $

    18,507

     

    $

    1,885

     

    $

    34,250

     

    $

    2,720

    Earnings attributable to Class A and Class B common stockholders

     

     

     

     

     

     

     

    Basic earnings per share

    $

    0.11

     

    $

    0.01

     

    $

    0.21

     

    $

    0.02

    Diluted earnings per share

    $

    0.10

     

    $

    0.01

     

    $

    0.19

     

    $

    0.02

    Weighted-average shares outstanding—basic

     

    165,003,284

     

     

    166,343,035

     

     

    163,462,072

     

     

    169,201,983

    Weighted-average shares outstanding—diluted

     

    190,008,150

     

     

    178,588,552

     

     

    179,486,886

     

     

    180,102,840

    FIGS, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

     

     

    Year ended

    December 31,

     

     

    2025

     

     

     

    2024

     

    Cash flows from operating activities:

     

     

     

    Net income

    $

    34,250

     

     

    $

    2,720

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

    Depreciation and amortization expense

     

    9,035

     

     

     

    6,694

     

    Deferred income taxes

     

    (544

    )

     

     

    6,648

     

    Non-cash operating lease cost

     

    9,996

     

     

     

    8,483

     

    Stock-based compensation

     

    26,874

     

     

     

    42,673

     

    Accretion of discount and accrued interest on available-for-sale securities

     

    (3,727

    )

     

     

    (6,499

    )

    Changes in operating assets and liabilities:

     

     

     

    Accounts receivable

     

    2,354

     

     

     

    (1,219

    )

    Inventory

     

    (12,207

    )

     

     

    3,281

     

    Prepaid expenses and other current assets

     

    1,068

     

     

     

    (2,544

    )

    Other assets

     

    356

     

     

     

    (737

    )

    Accounts payable

     

    8,757

     

     

     

    (5,332

    )

    Accrued expenses

     

    (21,289

    )

     

     

    33,950

     

    Accrued compensation and benefits

     

    11,505

     

     

     

    (1,623

    )

    Sales tax payable

     

    561

     

     

     

    556

     

    Gift card liability

     

    2,513

     

     

     

    1,364

     

    Deferred revenue

     

    (622

    )

     

     

    2,452

     

    Returns reserve

     

    298

     

     

     

    884

     

    Income tax payable

     

    1,548

     

     

     

    (2,211

    )

    Operating lease liabilities

     

    (9,655

    )

     

     

    (8,278

    )

    Other non-current liabilities

     

    99

     

     

     

    (100

    )

    Net cash provided by operating activities

     

    61,170

     

     

     

    81,162

     

    Cash flows from investing activities:

     

     

     

    Purchases of property and equipment

     

    (8,168

    )

     

     

    (17,021

    )

    Purchases of available-for-sale securities

     

    (256,992

    )

     

     

    (246,949

    )

    Maturities of available-for-sale securities

     

    201,400

     

     

     

    196,580

     

    Purchase of investment in equity securities

     

    (201

    )

     

     

    (27,534

    )

    Net cash used in investing activities

     

    (63,961

    )

     

     

    (94,924

    )

    Cash flows from financing activities:

     

     

     

    Repurchases of Class A Common Stock

     

    (2,688

    )

     

     

    (45,454

    )

    Proceeds from stock option exercises and employee stock purchases

     

    1,718

     

     

     

    438

     

    Issuance of Class A Common Stock upon vesting of restricted stock

     

    1

     

     

     

    —

     

    Issuance of Class A Common Stock in exchange for services

     

    —

     

     

     

    250

     

    Net cash used in financing activities

     

    (969

    )

     

     

    (44,766

    )

    Effect of foreign currency exchange rate changes on cash and cash equivalents

     

    100

     

     

     

    —

     

    Net decrease in cash and cash equivalents

     

    (3,660

    )

     

     

    (58,528

    )

    Cash and cash equivalents, beginning of period

    $

    85,645

     

     

    $

    144,173

     

    Cash and cash equivalents end of period

    $

    81,985

     

     

    $

    85,645

     

    FIGS, INC.

    RECONCILIATIONS OF GAAP TO NON-GAAP MEASURES

    (Unaudited)

     

    The following table presents a reconciliation of adjusted EBITDA to net income, which is the most directly comparable financial measure calculated in accordance with GAAP, and presents adjusted EBITDA margin with net income margin, which is the most directly comparable financial measure calculated in accordance with GAAP:

     

     

    Three Months Ended

    December 31,

     

     

    Year Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

     

    2025

     

     

     

    2024

     

     

    (in thousands, except margin)

    Net income

    $

    18,507

     

     

    $

    1,885

     

     

     

    $

    34,250

     

     

    $

    2,720

     

    Add (deduct):

     

     

     

     

     

     

     

     

    Other income, net

     

    (2,545

    )

     

     

    (3,481

    )

     

     

     

    (9,060

    )

     

     

    (12,075

    )

    Provision for income taxes

     

    2,846

     

     

     

    10,494

     

     

     

     

    12,957

     

     

     

    11,620

     

    Depreciation and amortization expense(1)

     

    2,557

     

     

     

    1,847

     

     

     

     

    9,035

     

     

     

    6,694

     

    Stock-based compensation and related expense(2)

     

    5,369

     

     

     

    10,331

     

     

     

     

    27,304

     

     

     

    42,837

     

    Adjusted EBITDA(3)

    $

    26,734

     

     

    $

    21,076

     

     

     

    $

    74,486

     

     

    $

    51,796

     

     

     

     

     

     

     

     

     

     

    Net Revenues

    $

    201,896

     

     

    $

    151,832

     

     

     

    $

    631,098

     

     

    $

    555,558

     

    Net income margin(4)

     

    9.2

    %

     

     

    1.2

    %

     

     

     

    5.4

    %

     

     

    0.5

    %

    Adjusted EBITDA Margin

     

    13.2

    %

     

     

    13.9

    %

     

     

     

    11.8

    %

     

     

    9.3

    %

    (1) Excludes amortization of debt issuance costs included in "Other income, net."

    (2) Includes stock-based compensation expense, payroll taxes, and costs related to equity award activity.

    (3) For the year ended December 31, 2025, reflects $171,000 of stock-based compensation expense and payroll taxes inadvertently not reflected in our previously disclosed Adjusted EBITDA results for the three months ended March 31, 2025.

    (4) Net income margin represents net income as a percentage of net revenues.

    The following table presents a reconciliation of free cash flow to net cash provided by operating activities, which is the most directly comparable financial measure calculated in accordance with GAAP:

     

     

    Year ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

    (in thousands)

    Net cash provided by operating activities

    $

    61,170

     

     

    $

    81,162

     

    Less: capital expenditures

     

    (8,168

    )

     

     

    (17,021

    )

    Free cash flow

    $

    53,002

     

     

    $

    64,141

     

    FIGS, INC.

    KEY OPERATING METRICS

    (Unaudited)

     

    Active customers as of December 31, 2025 and 2024, respectively, net revenues per active customer as of December 31, 2025 and 2024, respectively, and average order value for the years ended December 31, 2025 and 2024, respectively, are presented in the following tables:

     

     

    As of December 31,

     

    2025

     

    2024

     

    (in thousands)

    Active customers

    2,921

     

    2,670

     

    As of December 31,

     

     

    2025

     

     

    2024

    Net revenues per active customer

    $

    216

     

    $

    208

     

    Year ended

    December 31,

     

     

    2025

     

     

    2024

    Average order value

    $

    120

     

    $

    113

    FIGS, INC.

    DISAGGREGATED NET REVENUES

    (In thousands, except percentages)

     

    The following table presents the disaggregation of the Company's net revenues for the years and three months ended December 31, 2025 and December 31, 2024:

     

     

    Year ended

    December 31,

     

    Change

     

     

    2025

     

     

    2024

     

    %

    By geography:

     

     

     

     

     

    United States

    $

    527,466

     

    $

    474,305

     

    11.2

    %

    Rest of the world

     

    103,632

     

     

    81,253

     

    27.5

    %

     

    $

    631,098

     

    $

    555,558

     

    13.6

    %

    By product:

     

     

     

     

     

    Scrubwear

    $

    508,902

     

    $

    445,112

     

    14.3

    %

    Non-Scrubwear

     

    122,196

     

     

    110,446

     

    10.6

    %

     

    $

    631,098

     

    $

    555,558

     

    13.6

    %

     

    Three months ended

    December 31,

     

    Change

     

     

    2025

     

     

    2024

     

    %

     

    (Unaudited)

    By geography:

     

     

     

     

     

    United States

    $

    164,156

     

    $

    127,504

     

    28.7

    %

    Rest of the world

     

    37,740

     

     

    24,328

     

    55.1

    %

     

    $

    201,896

     

    $

    151,832

     

    33.0

    %

    By product:

     

     

     

     

     

    Scrubwear

    $

    154,903

     

    $

    114,653

     

    35.1

    %

    Non-Scrubwear

     

    46,993

     

     

    37,179

     

    26.4

    %

     

    $

    201,896

     

    $

    151,832

     

    33.0

    %

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260226021599/en/

    Investors:

    Tom Shaw

    [email protected]

    Media:

    Todd Maron

    [email protected]

    Get the next $FIGS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FIGS

    DatePrice TargetRatingAnalyst
    11/7/2025$7.00 → $9.00Market Perform
    Telsey Advisory Group
    10/15/2025$9.00Buy
    BTIG Research
    8/8/2025$5.00 → $7.00Market Perform
    Telsey Advisory Group
    5/5/2025$7.00 → $5.00Market Perform
    Telsey Advisory Group
    8/9/2024$6.00 → $7.00Market Perform
    Telsey Advisory Group
    4/2/2024$8.50 → $4.50Neutral → Underperform
    BofA Securities
    3/8/2024Outperform → Perform
    Oppenheimer
    2/29/2024$6.00Outperform → Market Perform
    Telsey Advisory Group
    More analyst ratings

    $FIGS
    SEC Filings

    View All

    SEC Form S-8 filed by FIGS Inc.

    S-8 - FIGS, Inc. (0001846576) (Filer)

    2/26/26 5:19:53 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    SEC Form 10-K filed by FIGS Inc.

    10-K - FIGS, Inc. (0001846576) (Filer)

    2/26/26 4:29:19 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FIGS, Inc. (0001846576) (Filer)

    2/26/26 4:13:15 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

    Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $9.00 from $7.00 previously

    11/7/25 7:47:45 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    BTIG Research initiated coverage on FIGS, Inc. with a new price target

    BTIG Research initiated coverage of FIGS, Inc. with a rating of Buy and set a new price target of $9.00

    10/15/25 8:28:19 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on FIGS, Inc. with a new price target

    Telsey Advisory Group reiterated coverage of FIGS, Inc. with a rating of Market Perform and set a new price target of $7.00 from $5.00 previously

    8/8/25 7:49:08 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FIGS Releases Fourth Quarter and Full Year 2025 Financial Results

    Exceeded Top and Bottom Line Expectations Grew Q4 2025 Net Revenues 33.0% to a Record $201.9 Million Achieved Q4 2025 Net Income Margin of 9.2% and Adjusted EBITDA Margin of 13.2% Plans Low Double-Digit Net Revenues Growth and Margin Expansion in FY 2026 FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Fourth Quarter 2025 Financial Highlights Net revenues were $201.9 million, an in

    2/26/26 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Participation in the Raymond James 47th Annual Institutional Investors Conference

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced that Trina Spear, Chief Executive Officer and Co-Founder, and Sarah Oughtred, Chief Financial Officer, are scheduled to participate in a fireside chat at the Raymond James 47th Annual Institutional Investors Conference on Wednesday, March 4, 2026, at 9:50 a.m. ET. The audio portion of the fireside chat will be webcast live over the internet and can be accessed at https://ir.wearfigs.com. An online archive will be available on that site for a period of 90 days following the fireside chat. About FIGS FIGS is a founder-led, direct-to-consumer h

    2/25/26 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Employ Inc. Appoints Jerry Jao as CEO

    DENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Employ Inc., a leading provider of people-first, intelligent hiring solutions across JazzHR, Lever, and Jobvite, today announced the appointment of Jerry Jao as CEO. Jao is a successful serial entrepreneur who founded three businesses, including the AI-powered marketing and personalization SaaS company ReSci (Retention Science), acquired by Constant Contact in 2020. During his executive career, he first encountered Employ as a Lever customer and spent six years using the platform, gaining firsthand insight into how its innovation helps hiring managers stay organized and save time across the hiring process. Jao shared, "Hiring has never needed to

    2/18/26 8:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Oughtred Sarah sold $239,606 worth of shares (22,690 units at $10.56), decreasing direct ownership by 3% to 821,500 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    2/9/26 8:17:59 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Executive Chair Hasson Heather L. sold $241,549 worth of shares (22,874 units at $10.56), decreasing direct ownership by 2% to 1,251,967 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    2/9/26 8:12:46 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Chief Financial Officer Oughtred Sarah sold $120,927 worth of shares (10,515 units at $11.50), decreasing direct ownership by 1% to 834,830 units (SEC Form 4)

    4 - FIGS, Inc. (0001846576) (Issuer)

    1/8/26 7:14:13 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Leadership Updates

    Live Leadership Updates

    View All

    Employ Inc. Appoints Jerry Jao as CEO

    DENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Employ Inc., a leading provider of people-first, intelligent hiring solutions across JazzHR, Lever, and Jobvite, today announced the appointment of Jerry Jao as CEO. Jao is a successful serial entrepreneur who founded three businesses, including the AI-powered marketing and personalization SaaS company ReSci (Retention Science), acquired by Constant Contact in 2020. During his executive career, he first encountered Employ as a Lever customer and spent six years using the platform, gaining firsthand insight into how its innovation helps hiring managers stay organized and save time across the hiring process. Jao shared, "Hiring has never needed to

    2/18/26 8:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Jerry Jao, former Chief Executive Officer of Retention Science, to its board of directors (the "Board"), effective April 1, 2025 (the "Effective Date"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250403714974/en/Jerry Jao Mr. Jao joins the Board as an independent director and has also been appointed to serve as both Chair of the Board's Audit Committee and as a member of the Board's Compensation Committee. Since May 2024, Mario Marte has served as

    4/3/25 8:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Updates to Board of Directors

    FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Melanie Whelan, former Chief Executive Officer of SoulCycle Inc., to its board of directors (the "Board"), effective January 1, 2025 (the "Effective Date"). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241219372097/en/Melanie Whelan (Photo: Business Wire) Ms. Whelan joins the Board as an independent director. Ms. Whelan has also been appointed to serve as Chair of the Board's Compensation Committee, which as of the Effective Date will consist of Ms.

    12/19/24 6:50:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FIGS Inc.

    SC 13G/A - FIGS, Inc. (0001846576) (Subject)

    11/14/24 1:28:33 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    SEC Form SC 13G filed by FIGS Inc.

    SC 13G - FIGS, Inc. (0001846576) (Subject)

    11/14/24 12:17:49 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by FIGS Inc.

    SC 13G/A - FIGS, Inc. (0001846576) (Subject)

    11/13/24 10:27:59 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $FIGS
    Financials

    Live finance-specific insights

    View All

    FIGS Releases Fourth Quarter and Full Year 2025 Financial Results

    Exceeded Top and Bottom Line Expectations Grew Q4 2025 Net Revenues 33.0% to a Record $201.9 Million Achieved Q4 2025 Net Income Margin of 9.2% and Adjusted EBITDA Margin of 13.2% Plans Low Double-Digit Net Revenues Growth and Margin Expansion in FY 2026 FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Fourth Quarter 2025 Financial Highlights Net revenues were $201.9 million, an in

    2/26/26 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Announces Date of Fourth Quarter and Full Year 2025 Earnings Release, Conference Call and Webcast

    FIGS, Inc. (NYSE:FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a fourth quarter and full year 2025 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx. FIGS Fourth Quarter and Full Year 2025 Earnings and Conference Call

    2/5/26 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary

    FIGS Releases Third Quarter 2025 Financial Results

    Exceeded Expectations on Both Top and Bottom Lines Grew Net Revenues 8.2%, Strongest Quarterly Growth Rate in Two Years Achieved Net Income Margin of 5.8% and Adjusted EBITDA Margin of 12.4% Increasing Full Year 2025 Outlook FIGS, Inc. (NYSE:FIGS) (the "Company"), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its third quarter 2025 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Third Quarter 2025 Financial Highlights Net revenues were $151.7 million, an increase of 8.2% year over year, primarily due to an i

    11/6/25 4:05:00 PM ET
    $FIGS
    Apparel
    Consumer Discretionary